Clovis Oncology (CLVS) Tops Q3 EPS by 25c

November 3, 2016 4:07 PM EDT
Get Alerts CLVS Hot Sheet
Trade CLVS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($1.70), $0.25 better than the analyst estimate of ($1.95).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment